EarningsStryker (SYK) Misses Q3 Estimates as Hip and Knee Procedures Slow
Stryker's revenue rose 7.7% to $6.52 billion, short of the $6.58 billion expected, and it cut its 2026 growth forecast. The stock was down 7.6% Friday morning.
SYK▲ 2.5%
Latest stories, page 2
Earnings
EarningsBristol Myers Squibb (BMY) Tops Q3 Estimates as Eliquis Sales Grow 26%
Bristol Myers Squibb's revenue rose 7% to $13.07 billion, beating the $12.56 billion Zacks consensus, and it raised its 2026 sales forecast. The stock rose 1.4% on Thursday.
BMY▲ 1.4%
EarningsAltria (MO) Tops Q3 Estimates as It Raises 2026 Profit Forecast
Altria's revenue net of excise taxes rose 3.6% to $5.44 billion, ahead of the $5.31 billion expected, and it raised its 2026 forecast. The stock jumped 5.2% on Thursday.
MO▲ 3.3%
EarningsIntercontinental Exchange (ICE) Tops Q3 Estimates as Exchange Revenue Grows 22%
ICE's net revenue rose 15% to $2.77 billion and adjusted EPS of $2.02 beat the $1.97 Zacks consensus. The stock jumped 4.5% on Thursday.
ICE▲ 4.5%
EarningsStarbucks (SBUX) Beats Q4 Profit Estimates but Revenue Falls Short
Starbucks earned an adjusted 80 cents a share, above the 72 cents expected, as global comparable sales rose 7.2%, but revenue fell 4% to $9.14 billion. The stock slipped 0.6% on Friday morning.
SBUX▲ 2.2%
EarningsKLA (KLAC) Tops Q1 Estimates as Chip-Inspection Sales Rise 29%
KLA's September-quarter revenue rose 29% to $4.14 billion, ahead of the $4.05 billion expected, and it guided to $4.7 billion for December. The stock rose 5.5% on Thursday.
KLAC▲ 5.5%
EarningsAmphenol (APH) Tops Q3 Estimates as AI Datacom Sales More Than Double
Amphenol's sales rose 65% to $10.23 billion, beating the $9.44 billion expected, as IT datacom sales jumped 117%. The stock rose 3.5% on Wednesday and 1.4% on Thursday.
APH▲ 1.4%
EarningsGE Vernova (GEV) Tops Q3 Estimates as Orders Nearly Double to $29 Billion
GE Vernova's revenue rose 27% to $12.64 billion, beating the $11.99 billion expected, as orders jumped 96%. The stock fell 1.9% on Wednesday, then rose 1.1% on Thursday.
GEV▲ 1.1%
EarningsGilead (GILD) Tops Q3 Estimates as HIV Sales Grow 18%
Gilead's revenue rose 7% to $8.30 billion, beating the $7.81 billion expected, and it raised its 2026 sales forecast. The stock was up 3% after hours.
GILD▲ 4.0%
EarningsMerck (MRK) Tops Q3 Estimates as Keytruda and Gardasil Outperform
Merck's sales rose 5% to $18.09 billion, ahead of the $17.31 billion expected, and it raised its 2026 profit forecast. The stock rose 3.8% on Thursday.
MRK▲ 3.8%
EarningsMastercard (MA) Tops Q3 Estimates as Value-Added Services Grow 19%
Mastercard's revenue rose 14% to $9.81 billion, ahead of the $9.63 billion expected, as services sales grew 19%. The stock jumped 4.2% to a 52-week closing high.
MA▲ 4.2%
EarningsShell (SHEL) Tops Q3 Estimates as Refining Margins Hit a Record
Shell's adjusted earnings nearly doubled to $10.81 billion, beating forecasts, and it raised its quarterly buyback to $5 billion. Its US shares rose 2.4% to $107.67.
SHEL▲ 2.4%